Brandon BioCatalyst delivers several health-focused programs alongside Australia’s leading deep-tech incubator Cicada Innovations at the Westmead Healthtech Hub.
The Cicada HealthTech Hub empowers innovators to commercialise bio, med, and health technologies through four targeted initiatives. These programs offer access to healthcare experts, industry networks, and tailored support, enabling startups and researchers to navigate the complexities of the healthcare market and fast-track their journey to market.
Westmead Health and Innovation District researchers can directly access the capital, and investment and commercialisation expertise of the Brandon Capital team via the Precinct’s participation in the Brandon BioCatalyst collaboration.
Explore what’s on at Cicada Innovations.
Bookable online, our office hour meetings offer individuals free guidance, mentorship, and support to activate ideas with the help of industry and subject matter experts. These sessions cover all aspects of the commercialisation pipeline and include regular meetings with the Brandon Capital team.
Program Structure: On demand 20 min confidential 1:1 consultation in-person or online.
Audience: All early-stage bio, med and health tech researchers, clinicians, founders, and the wider Westmead Health and Innovation District ecosystem.
Book via the Cicada Innovations website.
Brandon BioCatalyst’s activities in collaboration with the Cicada HealthTech Hub is proudly supported by Investment NSW, a part of the NSW Government.
Cicada Innovations was established in 2000 in Sydney with support from ANU, UNSW, USYD and UTS.
Its vision is to bring together the fields of business, engineering, and science to build businesses that solve complex global challenges and its mission is to further scientific discovery and help the next generation of innovators build impactful deep-tech companies.
The Cicada HealthTech Hub empowers innovators to commercialise bio, med, and health technologies through four targeted initiatives. These programs offer access to healthcare experts, industry networks, and tailored support, enabling startups and researchers to navigate the complexities of the healthcare market and fast-track their journey to market.
Explore what’s on at Cicada Innovations.
The district includes 4 major hospitals, 4 world-leading medical research institutes, 2 university campuses and the largest research-intensive pathology service in NSW.
By 2036, the number of full-time staff will increase to more than 50,000 and the number of students will expand to more than 10,000.
Among the first projects for development is a viral vector advanced manufacturing facility that will provide ground-breaking trial therapies for infections, cancer, and genetic diseases
